Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
IVDs
|
Imaging & IT
|
Cardiovascular
|
Orthopaedics
|
Surgical & Wound care
|
Cellular & Genetic
|
Neurological
|
Other
|
clinica
Market Sector - Cellular & Genetic
US FDA warns public of fraudulent stem cell schemes
10 January 2012
US regulators have warned consumers about fraudsters peddling potentially dangerous and ineffective stem cell treatments. They noted that only one stem cell product is approved by the US FDA – Hemacord, a haematopoietic progenitor cell product ...
S&N sells majority stake of orthobiologics unit to VC Essex to set up JV
04 January 2012
Smith & Nephew is selling a major stake in its non-core orthobiologics unit to healthcare private equity firm Essex Woodlands and the business will be set up as a joint venture. The transaction includes an injection of funds to S&N and is expected ...
Sanofi licenses regenerative osteoarthritis treatment from Scil
21 December 2011
Sanofi has exclusively licensed Scil Technology's preclinical stage programme for a regenerative treatment of osteoarthritis and cartilage disorders. Under the agreement, privately-held Scil of Germany will receive an upfront payment and potential ...
Baxter splashes out $325m on biomaterials firm Synovis
13 December 2011
Baxter International has boosted its regenerative and biosurgical offering by agreeing to acquire Synovis Life Technologies, which develops products for soft tissue repair during surgery. The deal is worth $28 per share, which equates to $325m of ...
Tissue Regenix: £25m funding allows firm to independently expand
09 December 2011
Regenerative medicine specialist Tissue Regenix has raised £25m ($39.3m) in a share placement to fund the further development of its dCELL vascular patch and other products. The money should cover the firm's activities until 2016-17, managing ...
 
Advanced Therapies: is the EU regulatory approach putting a brake on market development?
19 January 2012
There is no doubt that the European Medicines Agency's Committee for Advanced Therapies (CAT) has put considerable effort into developing a significant number of guidelines to explain how it operates in the complex field of advanced therapy ...
From women's health to cardiology: Cytori grows potential of cell-based technology
08 June 2011
In the past year, regenerative medicine specialist Cytori Therapeutics has been piecing together a puzzle that it hopes will lead to success for its lead product, the Celution system. Used to enrich fat grafts, it is already available for breast ...
Five Minutes with Matthew Walls of EpiStem 19 April 2010

Matthew Walls joined biotechnology firm Epistem as CEO in February 2007. The Manchester, UK-based firm focuses on stem cell technologies for use in therapeutic and biomarker applications. Before joining EpiStem, Mr Walls headed data management firm ...

 
Gene genie: the role of devices in gene therapy delivery 21 June 2010

Gene therapy has been hailed as the future of medicine, but has yet to fulfil its promise. Despite increased understanding of the genetics of various diseases, the problem of how to deliver therapeutic genes to their target tissues remains. Peter ...

 
 
COMPANY/ORGANISATION


Loading COMPANY/ORGANISATION ....
 
CONDITION


Loading CONDITION ....
 
GEOGRAPHY


Loading GEOGRAPHY ....
 
EVENTS
The 14th MedTech Investing Europe conference
19 March 2012
Montreux Convention and Music Centre, Switzerland
HTAi 2012
23 June 2012
Bilbao, Spain
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm